| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -718.1% | -493.3% |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 0.0 | 33.8 |
| Pr/Book | 0.0 |
| Latest | F'cast | |
|---|---|---|
| Revenue | -49.6% | -99.9% |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Apr-21 | 0.50 | (8.14) | (4.63)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-22 | 0.50 | (8.14) | (4.64)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-23 | 0.70 | (8.93) | (4.61)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-24 | 2,090.60 | (5,765.80) | (30.26)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-25 | 1,052.90 | (7,217.00) | (3.54)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Apr-26 | 1.50 | (7.40) | (3.80)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-27 | 2.00 | (8.50) | (4.10)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Half-year Financial Report | 22-Jan-2026 | 07:00 | RNS |
| Ilika Secures Stereax Electrode Order from Cirtec | 21-Jan-2026 | 07:00 | RNS |
| Initial Stereax M300 Shipments | 18-Dec-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 28.00p |
| Change Today | -2.00p |
| % Change | -6.67 % |
| 52 Week High | 51.00p |
| 52 Week Low | 27.11p |
| Volume | 420,631 |
| Shares Issued | 180.83m |
| Market Cap | £50.63m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:20 | 50,000 @ 27.50p |
| 16:29 | 100 @ 29.00p |
| 16:29 | 104 @ 29.00p |
| 16:28 | 106 @ 27.95p |
| 16:27 | 5,000 @ 27.95p |
You are here: research